Document Detail


Transmission of invasive Haemophilus influenzae type b disease in day care settings.
MedLine Citation:
PMID:  3497249     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We prospectively studied the risk of secondary transmission of invasive Haemophilus influenzae type b (Hib) disease among children in day care in Oklahoma. We established a statewide surveillance system for the reporting of all forms of invasive Hib disease from physicians, clinical laboratories, county health departments, and infection control practitioners from all hospitals in and bordering Oklahoma. For the 2-year period March 15, 1984, to March 15, 1986, there were 409 culture-confirmed cases of invasive Hib disease in children 12 years of age or younger; 147 (37%) case-patients attended day care. When a case-patient attended day care during the week before illness, we prospectively identified and observed all classroom contacts (n = 2147) for the next 60 days. Of 1253 classroom contacts younger than 4 years of age, seven (0.6%) secondary cases were identified. Isolates from all paired index and secondary cases had identical outer membrane protein (OMP) patterns. Strains causing primary disease were indistinguishable by OMP distribution from those causing secondary disease. Of 685 classroom contacts younger than 2 years of age from whom rifampin use was ascertained, five (1.7%) of 292 who did not receive rifampin became secondary cases, compared with one (0.3%) of 393 who received rifampin (rate ratio 6.7; 95% confidence limits 1.1, 42.5; P less than 0.05). Of 495 classroom contacts 24 to 47 months of age for whom rifampin use was ascertained, one (0.5%) of 194 who did not receive rifampin became a secondary case, compared with none of 301 who received rifampin. This experience indicates that secondary transmission of invasive Hib disease can be appreciable in day care settings, particularly in children younger than 2 years of age, and that rifampin prophylaxis reduces this risk.
Authors:
S Makintubee; G R Istre; J I Ward
Related Documents :
24740029 - An investigation of outpatient children's blood lead level in wuhan china.
9890619 - Basic fibroblast growth factor in experimental and clinical bacterial meningitis.
14725409 - Case fatality proportions and predictive factors for mortality among children hospitali...
17662169 - Invasive meningococcal disease in children in jerusalem.
1736169 - Magnetic resonance demonstration of intracranial csf flow in children.
16804429 - Site-specific disease potential of individual streptococcus pneumoniae serotypes in ped...
10342539 - Hypnotherapy: an effective treatment modality for trichotillomania.
17204219 - Late probing for congenital nasolacrimal duct obstruction.
22375909 - Some general considerations about the clinicopathologic aspects of soft tissue tumors i...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  The Journal of pediatrics     Volume:  111     ISSN:  0022-3476     ISO Abbreviation:  J. Pediatr.     Publication Date:  1987 Aug 
Date Detail:
Created Date:  1987-09-10     Completed Date:  1987-09-10     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375410     Medline TA:  J Pediatr     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  180-6     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Child
Child Day Care Centers*
Child, Preschool
Drug Evaluation
Haemophilus Infections / epidemiology,  prevention & control,  transmission*
Haemophilus influenzae / isolation & purification
Humans
Infant
Oklahoma
Prospective Studies
Rifampin / therapeutic use
Risk
Chemical
Reg. No./Substance:
13292-46-1/Rifampin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of milk protein and fat intake on blood pressure and the incidence of cerebrovascular disease...
Next Document:  Granulocyte elastase-alpha 1-antiproteinase complex in cystic fibrosis: sensitive plasma assay for m...